Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Castleberry

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Cancer Research|October 15, 1995
Significance of chromosome 1p loss of heterozygosity in neuroblastomaJ M Maris, P S White, C P Beltinger, et al.
The New England Journal of Medicine|December 22, 1994
A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemiaR P Castleberry, P D Emanuel, K S Zuckerman, et al.
Cancer|July 1, 1985
Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group studyV J Land, P R Thomas, J M Boyett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastomaR P Castleberry, L E Kun, J J Shuster, et al.
Lancet (London, England)|February 9, 1991
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma ScreeningS B Murphy, S L Cohn, A W Craft, et al.
Medical and Pediatric Oncology|March 1, 1995
Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II studyN B McWilliams, F A Hayes, A A Green, et al.
Cancer|April 15, 1992
Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Progress in Clinical and Biological Research|January 1, 1988
International criteria for diagnosis, staging and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Journal of the National Cancer Institute|March 5, 1997
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group studyL C Bowman, R P Castleberry, A Cantor, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Cancer Research|October 15, 1995
Significance of chromosome 1p loss of heterozygosity in neuroblastomaJ M Maris, P S White, C P Beltinger, et al.
The New England Journal of Medicine|December 22, 1994
A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemiaR P Castleberry, P D Emanuel, K S Zuckerman, et al.
Cancer|July 1, 1985
Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group studyV J Land, P R Thomas, J M Boyett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastomaR P Castleberry, L E Kun, J J Shuster, et al.
Lancet (London, England)|February 9, 1991
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma ScreeningS B Murphy, S L Cohn, A W Craft, et al.
Medical and Pediatric Oncology|March 1, 1995
Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II studyN B McWilliams, F A Hayes, A A Green, et al.
Cancer|April 15, 1992
Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Progress in Clinical and Biological Research|January 1, 1988
International criteria for diagnosis, staging and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Journal of the National Cancer Institute|March 5, 1997
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group studyL C Bowman, R P Castleberry, A Cantor, et al.
Pageof 8